FEBS Letters
Volume 582, Issue 15 , Pages 2188-2194, 25 June 2008

Human but not rat amylin shares neurotoxic properties with Aβ42 in long-term hippocampal and cortical cultures

Edited by Jesus Avila

Alzheimer’s and Parkinson’s Disease Laboratory, Brain and Mind Research Institute, University of Sydney, 100 Mallett Street, Camperdown, NSW 2050, Australia

Received 3 February 2008; received in revised form 22 April 2008; accepted 5 May 2008. published online 15 May 2008.

Abstract 

Type 2 diabetes mellitus (DM) and Alzheimer’s disease (AD) share epidemiological and biochemical features. Both are characterized by insoluble protein aggregates with a fibrillar conformation – amylin in Type 2 DM pancreatic islets, and Aβ in AD brain. To determine whether amylin shares neurotoxic properties with Aβ, we incubated hippocampal and cortical neurons with Aβ42 and human amylin. Different from non-amyloidogenic rat amylin, both caused a dose-, time- and cell type-specific neurotoxicity supporting the notion of a similar toxic mechanism. Depending on the cell type, this finding is also supported by co-incubation of human amylin and Aβ.

Keywords: Aβ42 amyloid, Alzheimer’s disease, Amylin, Cell-type specificity, Conformational disease, IAPP, Neurotoxicity, Type 2 diabetes mellitus

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(08)00403-1

doi:10.1016/j.febslet.2008.05.006

FEBS Letters
Volume 582, Issue 15 , Pages 2188-2194, 25 June 2008